KFDA to draft approval of protocol on drug

Published: 2002-11-08 06:59:00

Updated: 2002-11-08 06:59:00

The approval for revision of a clinical trial protocol on drug will be simplified and new drugs for clinical trial purpose may be administered to patients to a terminal-phase cancer and AIDS prior to market authorization, the Korea Food and Drug Administration (KFDA) said recently.

In parallel...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK